Invesco S&P 500 Equal Weight Health Care ETF (NY:RSPH)

41.17 -0.23 (-0.56%)

Delayed Quote Updated: 1:43 PM EST, Nov 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Invesco S&P 500 Equal Weight Health Care ETF

Decoding Healthcare ETFs: Different Sectors, Different Strategies ↗

November 07, 2026

RSPH offers broader sector diversification with lower volatility, while XBI delivers higher short-term gains but with steeper drawdowns.

Via The Motley Fool

Topics ETFs

Which Healthcare ETF Is the Better Buy: Invesco’s Broad RSPH or First Trust’s Biotech FBT? ↗

October 26, 2026

FBT has outperformed RSPH by a wide margin recently. The question is whether you want to own the fund that won last year or the one built to hold up over many years.

Via The Motley Fool

Topics ETFs

Invesco’s RSPH or iShares’ IBB: Which Healthcare ETF Is the Better Long-Term Buy? ↗

October 26, 2026

RSPH offers broader healthcare exposure with lower volatility and higher dividend yield, while IBB provides concentrated biotech focus with stronger recent returns.

Via The Motley Fool

Topics ETFs

VanEck Biotech vs. Invesco Healthcare: Which ETF Offers More Potential for Long-Term Growth? ↗

October 25, 2026

These two healthcare ETFs offer investors exposure to some of medicine's biggest names, but their different approaches to investing could lead to very different results.

Via The Motley Fool

Topics ETFs

Better Invesco Healthcare ETF: PJP Targeting Pharmaceuticals vs. RSPH's Broader Sector Lens ↗

October 11, 2026

PJP's one-year return beats RSPH's, but RSPH offers broader diversification across 61 healthcare holdings at a lower expense ratio.

Via The Motley Fool

Topics ETFs

PBE vs. RSPH: Is a Biotech ETF or Equal-Weight Healthcare ETF the Better Choice for Investors? ↗

September 15, 2026

PBE offers higher income and stronger returns, while RSPH provides broader diversification with lower costs and drawdown risk.

Via The Motley Fool

Topics ETFs

Should You Bet Big on Drugmakers? VanEck Pharmaceutical ETF vs. Invesco Healthcare ETF Compared. ↗

September 11, 2026

PPH offers concentrated pharma exposure with 1.9% yield and lower volatility, while RSPH provides broader diversification across 60 healthcare holdings.

Via The Motley Fool

Topics ETFs

Does iShares Pharma ETF Offer Superior Returns to Invesco's Equal Weight Healthcare Fund? ↗

September 08, 2026

IHE's concentrated pharma holdings delivered 50% returns over one year, while RSPH's equal-weight healthcare approach generated 29%. Risk profiles differ sharply too.

Via The Motley Fool

Topics ETFs

This Healthcare ETF Is Outperforming the Invesco Equal Weight Fund -- and It Offers a Charitable Twist ↗

August 13, 2026

Active management and concentrated bets drove a 42% one-year return, though the lower-cost Invesco alternative offers broader diversification across 60 healthcare stocks.

Via The Motley Fool

Topics ETFs

Which Is the Better Invesco Healthcare ETF: Equal-Weight RSPH or Biotech-Focused IBBQ? ↗

August 12, 2026

RSPH levels the playing field across 60 established healthcare names while IBBQ bets on more than 250 biotech companies at a lower cost.

Via The Motley Fool

Topics ETFs

Better Healthcare ETF: State Street's Pharmaceuticals-Focused XPH vs. Invesco's S&P 500-Targeted RSPH ↗

August 12, 2026

One fund targets pharma exclusively and surged 63% in a year, while the other diversifies across healthcare with lower volatility.

Via The Motley Fool

Topics ETFs Stocks

Which Healthcare ETF Is the Better Buy: Fidelity's FHLC or Invesco's Equal-Weight RSPH? ↗

July 31, 2026

FHLC's 0.08% expense ratio and market-cap approach delivered stronger returns, while RSPH's equal-weight strategy offers lower volatility and broader diversification across 60 holdings.

Via The Motley Fool

Topics ETFs

IXJ vs. RSPH: Which Healthcare ETF Is the Better Buy? ↗

July 21, 2026

IXJ offers a higher dividend yield and lower volatility with global exposure, while RSPH's equal-weight approach posted a stronger 1-year return.

Via The Motley Fool

Topics ETFs

Healthcare Investing in 2026: iShares Global Healthcare ETF Outperforms Invesco Health Care ETF ↗

July 16, 2026

IXJ's market-cap weighting and international exposure delivered stronger five-year returns and lower volatility, while offering double the dividend yield.

Via The Motley Fool

Topics ETFs

Invesco Healthcare ETF vs VanEck Biotech: Which ETF Will Deliver the Healthiest Returns for 2026? ↗

July 14, 2026

RSPH offers 60 diversified holdings with lower volatility, while BBH concentrates on 25 biotech leaders with stronger recent returns.

Via The Motley Fool

Topics ETFs

Invesco's RSPH vs. PJP: Which Health Care ETF Is the Better Fund For The GLP-1 Revolution? ↗

June 15, 2026

Compare portfolio strategies, cost structures, and risk profiles as two Invesco healthcare ETFs take different paths to sector exposure.

Via The Motley Fool

Topics ETFs

State Street's Health Care ETF Tops Invesco's on Yield and Returns ↗

June 02, 2026

Expense ratios, dividend yields, and risk profiles set these healthcare ETFs apart. See how their strategies shape long-term performance for investors.

Via The Motley Fool

Topics ETFs

Apple, Western Union, Palo Alto And More On CNBC's 'Final Trades' ↗

November 07, 2025

Apple, Palo Alto and Western Union are among the companies mentioned on the latest edition of CNBC's "Final Trades."

Via Benzinga

Tesla And Amazon Just Became A Problem For The Entire Discretionary Sector ↗

October 06, 2025

The consumer discretionary sector is underperforming due to stock concentration in Tesla and Amazon, but smaller companies in the sector are quietly delivering steady gains.

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.